Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End User (Hospital, Home Care) - Global Forecast to 2026
[421 Pages Report] The respiratory care devices market is expected to reach USD 27.6 billion by 2026 from USD 18.4 billion in 2021, at a CAGR of 8.5% during the forecast period of 2021 to 2026. Due to the outbreak of corona virus globally, there is a sudden rise in the demand for respiratory care devices. The major factor driving the growth of the market is the high prevalence of respiratory diseases as a result of the rapid growth in the global geriatric population, high prevalence of tobacco smoking, urbanization and growing levels of pollution, and changing lifestyle. However, factors such as the presence of an unfavorable reimbursement scenario and the availability of low-cost products from local manufacturers are expected to restrain the growth of this market during the forecast period.
In this report, the respiratory care devices market is segmented on the basis of product, disease indication, end user, and region.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 Impact on the Global Respiratory Care Devices Market
The COVID-19 outbreak in Wuhan, China, led to the rapid establishment of several hospitals for treating the increasing number of patients. This has been mirrored in other countries as well—Italy and the US also built large hospitals within days to accommodate a growing patient population. In New York, US, the army converted the Javits convention center into a 2,900-bed hospital within four days. Critical care devices are being manufactured in increased quantities to meet growing demand. The state of affairs resulting from the pandemic has resulted in alliances between healthcare and non-healthcare industries to manufacture respiratory care devices
Respiratory Care Devices Market Dynamics
Drivers: Outbreak of infectious diseases affecting the respiratory system
Infectious respiratory diseases directly drive demand for respiratory care. COVID-19 is the most recent and significant of these diseases; the pandemic has resulted in a surge in demand for personal protection equipment and ventilators, among others. The demand for ventilators has also grown due to the COVID-19 outbreak, resulting in governmental and industrial support for driving the pace of manufacturing. This is indicative of the emphasis on respiratory care in the background of an outbreak; the market is expected to show a healthy growth rate, as a result.
Restrains: Unfavorable reimbursement scenario
Many patients rely on reimbursements to receive treatment. The diagnostic industry as a whole and respiratory care diagnostics, in particular, is presently facing the challenge of lack of reimbursements for various diagnostic tests. Reimbursement policies are dispersed in Europe and are available only for PAP devices and oral appliances in select countries (devices that are not covered by insurance have a low market share in the region). Also, the majority of countries in the Asian and RoW regions have negligible reimbursement coverage for respiratory care devices.
Opportunities: Growing demand for home care therapeutic devices
The rapid growth in the global geriatric population, rising incidence of chronic diseases (including COPD and asthma), and the cost advantages of home care devices and services (compared to hospital visits) are the key factors driving the growth of the home healthcare market. The high growth potential in emerging markets, healthcare decentralization, and the evolution of miniaturized devices are some of the major factors that are expected to provide significant growth opportunities to players operating in the respiratory home healthcare market. Owing to the rising healthcare costs, a large number of patients suffering from chronic respiratory diseases prefer to undergo treatments in home care settings. This trend is expected to increase the demand for products such as nebulizers, ventilators, and CPAP devices, as they are used by patients to treat, diagnose, and monitor a variety of respiratory diseases in home care settings.
Challenges: Low awareness and large underdiagnosed and undertreated population
In spite of the high prevalence of major respiratory diseases such as asthma and COPD remain highly underdiagnosed and undertreated. This is particularly evident in developing economies due to the low awareness about these diseases and the unavailability of adequate resources to diagnose these diseases. According to the WHO, more than 90% of COPD deaths and 80% of asthma deaths occur in low- and middle-income countries. COPD develops slowly, and it is usually diagnosed in people aged over 40 years, which makes it difficult to control in the later stages of life. It is estimated that around 70% of COPD patients are underdiagnosed owing to the lack of awareness about the disease. Similar to COPD, asthma is also a highly underdiagnosed and undertreated disease (in around 50% asthmatics).
Respiratory care devices market Interconnections
The inhalers segment is estimated to grow at the highest CAGR in the market, during the forecast period.
Based upon product, the respiratory care devices market is segmented into therapeutic devices, monitoring devices, diagnostic devices, and consumables & accessories. In 2020, the therapeutic devices segment accounted for the largest share of the market. The different types of therapeutic devices covered in this report are humidifiers, nebulizers, oxygen concentrators, positive airway pressure (PAP) devices, reusable resuscitators, ventilators, inhalers, masks, nitric oxide delivery units, and oxygen hoods Inhalers segment is anticipated to witness the highest CAGR amongst therapeutic devices. Inhalers are widely used in the treatment of major respiratory ailments. They are categorized as metered-dose inhalers (MDIs) and dry-powder inhalers (DPIs). The high incidence of asthma is a key factor driving the growth of the global inhalers market in the forecast period.
The COPD segment will continue to dominate the respiratory care devices indication market during the forecast period
Based on indication, COPD held the largest share of the market in 2019. This was followed by sleep apnea, asthma, and infectious diseases. The large share of COPD segment can be attributed to the increasing prevalence of smoking and environmental factors. This segment is also expected to show the highest growth in the market, followed by asthma. Moreover, the recent outbreak of COVID-19 will also have an impact on COPD patients. While they are not at a higher risk of contracting the disease, it can have severe effects on such patients. Hence, the high prevalence of COPD and the growing number of deaths caused by COPD are expected to drive the demand for respiratory care devices during the forecast period.
Hospitals are the largest end users of respiratory care devices
Based on end user, the respiratory care devices market is segmented into broadly categorized into three major end-user segments—hospitals, home care settings, and ambulatory care centers. In 2019, hospitals accounted for the largest market share. Growing public-private partnerships to improve access to healthcare services along with rapid developments in healthcare infrastructure and improving access to healthcare services are expected to be the key factors driving the growth of the market for hospitals in emerging economies in the coming years.
Asia Pacific market to witness the highest growth during the forecast period
the respiratory care devices market is divided into five regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. These regions are further analyzed at the country levels. North America held the largest share of the market in 2019, followed by Europe and the Asia Pacific. The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, due to due to the presence of a large pool of respiratory patients, increasing healthcare expenditure, rapidly developing healthcare infrastructure, rising per capita income, growing middle-class population, and growing prevalence of tobacco smoking in this region. Also, APAC is becoming a medical tourism hub and is considered as one of the fastest-growing markets for medical procedures and devices. Low infrastructure and treatment costs and the availability of highly educated physicians have driven medical tourists to APAC countries, particularly India and China.
To know about the assumptions considered for the study, download the pdf brochure
Key Market Players
Some of the key players operating in the respiratory care devices market include Philips Healthcare (Netherlands), ResMed Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US) among others.
The study categorizes the market based on product, disease indications, end user, component at the regional and global level.
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market Size Available for Years |
2019–2026 |
|
Base Year Considered |
2020 |
|
Forecast Period |
2021–2026 |
|
Forecast Unit |
Value (USD Billion) |
|
Segments Covered |
Product, Disease Indications, and End User |
|
Geographies Covered |
|
|
Companies Covered |
Philips Healthcare (Netherlands), ResMed Inc. (US), Medtronic plc. (Ireland), Masimo Corporation (US), Fisher & Paykel Healthcare (New Zealand), Drager AG (Germany), Invacare Corporation (US), Nihon Kohden (Japan), Getinge AB (Sweden) and Air Liquide (France) among others. |
The research report categorizes the global market into the following segments and sub-segments:
By Product
- Therapeutic Respiratory Care Devices
- Positive Airway Pressure (PAP) Devices
- CPAP Devices
- APAP Devices
- BiPAP Devices
- Oxygen concentrator
- Fixed Oxygen Concentrators
- Portable Oxygen Concentrators
- Ventilators
- ICU Ventilators
- High-end ICU Ventilators
- Mid-end ICU Ventilators
- Basic ICU Ventilators
- Portable/Transportable Ventilators
- ICU Ventilators
- Inhalers
- Metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Humidifiers
- Heated Humidifiers
- Passover Humidifiers
- Reusable Resuscitators
- Adult Resuscitators
- Infant/Neonatal Resuscitators
- Nitric Oxide Delivery Units
- Oxygen Hoods
- Positive Airway Pressure (PAP) Devices
- Respiratory Care Monitoring Devices
- Pulse Oximeters
- Pulse Oximeter Equipment
- Pulse Oximeter Sensors
- Capnography
- Gas Analyzers
- Pulse Oximeters
- Diagnostic Respiratory Care Devices
- Spirometers
- Polysomnography Devices
- Peak Flow Meters
- Other Diagnostic Devices
- Consumables and Accessories
- Masks
- Reusable Masks
- Disposable Masks
- Disposable Resuscitators
- Tracheostomy Tubes
- Breathing Circuits
- Nasal Cannulae
- Other Consumables and Accessories
- Masks
By Disease Indications
- COPD
- Sleep Apnea
- Asthma
- Infectious Diseases
- Others
By End User
- Hospitals
- Home Care
- Ambulatory Care
Recent Developments
- In April 2020, Philips launched the PHILIPS RESPIRONICS E30 VENTILATOR. This will enable company to help healthcare professionals by providing superior quality ventilators
- In January 2020, Masimo Corporation acquired Connected Care Business from NantHealth (US). This acquisition will support Masimo to assist hospitals in providing constant care through connectivity, automation, and innovative noninvasive monitoring technologies.
- In May 2020, Philips did the partnership with Masimo. This partnership was aimed at integrating Masimo’s measurement technologies into select intellivue MX-Series multi-parameter monitors to help clinicians examine ventilation status and cerebral oximetry.
- In March 2019, ResMed acquired HB Healthcare Safety, a provider of home-based medical equipment for sleep and respiratory care devices.
Frequently Asked Questions (FAQs):
Which type of products is leading the by type segment?
The respiratory care devices market is segmented broadly into the therapeutic devices, monitoring devices, diagnostic devices, and consumables & accessories. In 2019, the therapeutic devices segment accounted for the largest share of the respiratory care devices market.
Which is the leading end user for respiratory care devices market?
The end users of the respiratory care devices market is segmented into in to three major end user segments—hospitals, home care settings, and ambulatory care centers. In 2019, hospitals accounted for the largest market share. Growing public-private partnerships to improve access to healthcare services along with rapid developments in healthcare infrastructure and improving access to healthcare services are expected to be the key factors driving the growth of the market for hospitals in emerging economies in the coming years.
Which is the leading indication of respiratory care devices market?
Based on indication, COPD held the largest share of the respiratory care devices market in 2019. This was followed by sleep apnea, asthma, and infectious diseases. The large share of COPD segment can be attributed to the increasing prevalence of smoking and environmental factors. This segment is also expected to show the highest growth in the market, followed by asthma. Moreover, the recent outbreak of COVID-19 will also have an impact on COPD patients. While they are not at a higher risk of contracting the disease, it can have severe effects on such patients. Hence, the high prevalence of COPD and the growing number of deaths caused by COPD are expected to drive the demand for respiratory care devices during the forecast period.
Who are the key players operating in the respiratory care devices market?
The respiratory care devices market is highly competitive and fragmented. The prominent players operating in this market include Philips Healthcare (Netherlands), ResMed Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Drager AG (Germany), Invacare Corporation (US), Nihon Kohden (Japan), Getinge AB (Sweden), Air Liquide (France), Invacare Corporation (US), Vyaire Medical (US), GE Healthcare (US), Nonin Medical Inc. (US), Apex Medical Corp. (Taiwan), Smiths Group (UK), Omron Healthcare Inc. (US), Allied Healthcare Products, Inc. (US), Teleflex Incorporated (US), Drive DeVilbiss Healthcare (US), 3B Medical, Inc. (US), Medline Industries, Inc. (US), Acare Technology Co. (Taiwan), Hill-Rom Holdings, Inc. (US), and Rotech Healthcare, Inc. (US).
Which geographical region is dominating in respiratory care devices market?
The respiratory care devices market is segmented into North America, Europe, the Asia Pacific, Latin America and Middle East and Africa. In 2019, North America dominated the global market, followed by Europe. However, the Asia Pacific market is estimated to register the highest CAGR during the forecast period. The growth of this market can be attributed to the large patient pool in the region, increasing prevalence of respiratory diseases & disorders, outbreak of infectious diseases and changing lifestyle. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 34)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION AND SCOPE
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 RESPIRATORY CARE DEVICES MARKET: SEGMENTATION
FIGURE 2 GLOBAL MARKET, BY REGION
1.2.3 YEARS CONSIDERED FOR THE MARKET STUDY
1.3 CURRENCY
TABLE 1 THE ANNUAL AVERAGE EXCHANGE RATES USED FOR CURRENCY CONVERSIONS TO USD
1.4 STAKEHOLDERS
1.5 LIMITATIONS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 39)
2.1 RESEARCH APPROACH
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
TABLE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC
FIGURE 9 SUPPLY-SIDE ANALYSIS: RESPIRATORY CARE DEVICES MARKET (2020)
FIGURE 10 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE GLOBAL MARKET(2021–2026)
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 12 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ASSUMPTIONS
FIGURE 14 ASSUMPTIONS FOR THE STUDY
2.5 RISK ASSESSMENT
TABLE 3 RISK ASSESSMENT: RESPIRATORY CARE DEVICES MARKET
3 EXECUTIVE SUMMARY (Page No. - 53)
FIGURE 15 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 16 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020 VS. 2026 (USD MILLION)
FIGURE 17 GLOBAL MARKET, DISEASE INDICATIONS, 2021 VS. 2026 (USD MILLION)
FIGURE 18 GLOBAL MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 19 GEOGRAPHIC SNAPSHOT: GLOBAL MARKET
4 PREMIUM INSIGHTS (Page No. - 58)
4.1 RESPIRATORY CARE DEVICES MARKET: MARKET OVERVIEW
FIGURE 20 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE THE MARKET GROWTH DURING THE FORECAST PERIOD
4.2 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, 2020
FIGURE 21 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE GLOBAL MARKET IN NORTH AMERICA IN 2020
4.3 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 22 CHINA TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
4.4 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC MIX
FIGURE 23 NORTH AMERICA WILL CONTINUE TO DOMINATE THE GLOBAL MARKET DURING THE FORECAST PERIOD
4.5 RESPIRATORY CARE DEVICES MARKET: DEVELOPING VS. DEVELOPED MARKETS
FIGURE 24 DEVELOPING MARKETS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 62)
5.1 INTRODUCTION
FIGURE 25 MARKET DYNAMICS: IMPACT ANALYSIS
5.2 MARKET DRIVERS
5.2.1 RISING PREVALENCE OF RESPIRATORY DISEASES
5.2.1.1 Rapid growth in the global geriatric population
FIGURE 26 GLOBAL GERIATRIC POPULATION, BY REGION
5.2.1.2 Urbanization and growing pollution levels
FIGURE 27 DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE (~EVERY YEAR)
5.2.1.3 High prevalence of tobacco smoking
TABLE 4 PREVALENCE AND DEATHS CAUSED DUE TO LIFESTYLE DISEASES
5.2.1.4 Changing lifestyles
5.2.2 INCREASING INCIDENCE RATE OF PRETERM BIRTHS
TABLE 5 THE 10 COUNTRIES WITH THE HIGHEST NUMBER OF PRETERM BIRTHS
TABLE 6 THE 10 COUNTRIES WITH THE HIGHEST RATES OF PRETERM BIRTH PER 100 LIVE BIRTHS
5.2.3 OUTBREAK OF INFECTIOUS DISEASES AFFECTING THE RESPIRATORY SYSTEM
5.2.4 UNDERPENETRATED MARKETS IN SLEEP AND COPD
5.2.5 FOCUS ON IMPROVING PATIENT OUTCOMES
5.2.6 RISING R&D INVESTMENTS RESULTING IN TECHNOLOGICALLY ADVANCED DEVICES
TABLE 7 PRODUCT LAUNCHES
FIGURE 28 R&D EXPENDITURE (% OF TOTAL REVENUE) BY KEY PLAYERS (2020 VS 2019)
5.3 MARKET RESTRAINTS
5.3.1 UNFAVORABLE REIMBURSEMENT SCENARIO
5.3.2 AVAILABILITY OF LOW-COST PRODUCTS FROM LOCAL MANUFACTURERS
5.3.3 HIGH COST OF CPAP MACHINES
5.4 MARKET OPPORTUNITIES
5.4.1 GROWING DEMAND FOR HOME CARE THERAPEUTIC DEVICES
5.4.2 HIGH GROWTH IN DEVELOPING COUNTRIES ACROSS THE ASIA PACIFIC AND LATIN AMERICA
5.4.3 POINT-OF-CARE DIAGNOSTICS
5.4.4 GROWING AWARENESS ABOUT THE ILL-EFFECTS OF UNTREATED SLEEP APNEA
TABLE 8 INITIATIVES TO PROMOTE AWARENESS ABOUT THE ILL EFFECTS OF UNTREATED SLEEP APNEA
5.5 MARKET CHALLENGES
5.5.1 LOW AWARENESS AND A LARGE UNDERDIAGNOSED AND UNDERTREATED POPULATION
5.5.2 HARMFUL EFFECTS OF CERTAIN DEVICES ON NEONATES
5.5.3 LACK OF PATIENT COMPLIANCE
6 INDUSTRY INSIGHTS (Page No. - 76)
6.1 INDUSTRY TRENDS
6.1.1 RISING DEMAND FOR ENHANCED COMPACT & PORTABLE DEVICES
6.1.2 KEY FOCUS OF MARKET PLAYERS ON GEOGRAPHICAL EXPANSIONS
6.1.3 GROWING DEMAND FOR MULTIMODAL VENTILATION
6.1.4 RISING ADOPTION OF NONINVASIVE VENTILATION
FIGURE 29 IMPACT ON PATIENT’S LIVES WITH THE INTRODUCTION OF INNOVATIVE SOLUTIONS FOR UNMET PATIENT NEEDS
FIGURE 30 INTRODUCTION OF INNOVATIVE SOLUTIONS LOWERING THE OVERALL COSTS FOR SLEEP APNEA TREATMENT
6.2 REGULATORY ANALYSIS
6.2.1 NORTH AMERICA
6.2.1.1 US
TABLE 9 US: CLASSIFICATION OF MEDICAL EQUIPMENT
TABLE 10 US: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
6.2.1.2 Canada
TABLE 11 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
6.2.1.3 Europe
TABLE 12 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
6.2.1.4 Asia Pacific
6.2.1.4.1 Japan
TABLE 13 JAPAN: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
6.2.1.4.2 China
TABLE 14 CHINA: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
6.2.1.4.3 India
6.3 ECOSYSTEM ANALYSIS
FIGURE 31 RESPIRATORY CARE DEVICES MARKET: ECOSYSTEM ANALYSIS
6.4 VALUE CHAIN ANALYSIS
FIGURE 32 VALUE CHAIN: RESPIRATORY CARE DEVICES MARKET
6.5 COVID-19 IMPACT ON THE GLOBAL MARKET
6.6 TECHNOLOGY TRENDS
6.6.1 E-NOSE TECHNOLOGY
6.6.2 MEMS TECHNOLOGY
6.6.3 ELECTROCHEMICAL TECHNOLOGY
6.6.4 WIRELESS GAS SENSOR TECHNOLOGY
6.7 ARTIFICIAL INTELLIGENCE IN THE VENTILATORS MARKET
6.7.1 INTRODUCTION
6.7.2 THE FUTURE OF HEALTHCARE—BIG DATA AND ARTIFICIAL INTELLIGENCE
6.7.3 KNOWLEDGE-BASED SYSTEMS FOR VENTILATION MANAGEMENT
6.7.4 COVID-19 TO DRIVE THE DEMAND FOR ARTIFICIAL INTELLIGENCE IN VENTILATORS
6.8 SENSOR TECHNOLOGIES IN VENTILATORS
6.8.1 INTRODUCTION
6.8.2 FLOW SENSORS
6.8.3 OXYGEN SENSORS
6.8.4 PRESSURE SENSORS
6.9 PATENT ANALYSIS
6.9.1 PATENT PUBLICATION TRENDS
FIGURE 33 PATENT PUBLICATION TRENDS: 2010 TO 2021
6.9.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR RESPIRATORY CARE DEVICE PATENTS
TABLE 15 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR RESPIRATORY CARE DEVICE PATENTS
FIGURE 34 JURISDICTION ANALYSIS FOR THE US (2014-2021)
6.10 TRADE ANALYSIS
TABLE 16 TOP EXPORTERS OF MEDICAL VENTILATORS; CPAP; BIPAP; OXYGEN CONCENTRATORS, 2018 (IN USD MN)
TABLE 17 INDIA THERAPEUTIC RESPIRATION APPARATUS; OZONE, OXYGEN, AEROSOL THERAPY APPARATUS; ARTIFICIAL RESPIRATION OR OTHER THERAPEUTIC RESPIRATION APPARATUS EXPORTS BY COUNTRY, 2019 (IN 000’)
6.11 YC-YCC SHIFT: RESPIRATORY CARE DEVICES MARKET
FIGURE 35 YC-YCC SHIFT IN THE GLOBAL MARKET
6.12 CASE STUDIES
TABLE 18 REPLACEMENT PATTERN OF VENTILATORS: DEVELOPED ECONOMIES VS. DEVELOPING ECONOMIES
TABLE 19 VOLUME DATA OF VENTILATORS, ICU VENTILATORS, PORTABLE VENTILATORS, PAP DEVICES, CPAP DEVICES, BIPAP DEVICES AND SPIROMETERS
6.13 PORTER’S FIVE FORCES ANALYSIS
TABLE 20 PORTER’S FIVE FORCES ANALYSIS
6.13.1 THREAT OF NEW ENTRANTS
6.13.2 THREAT OF SUBSTITUTES
6.13.3 BARGAINING POWER OF MANUFACTURERS
6.13.4 BARGAINING POWER OF BUYERS
6.13.5 INTENSITY OF COMPETITIVE RIVALRY
7 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT (Page No. - 97)
7.1 INTRODUCTION
TABLE 21 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 22 GLOBAL MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2 THERAPEUTIC RESPIRATORY CARE DEVICES
TABLE 23 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 24 THERAPEUTIC GLOBAL MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.1 PAP DEVICES
TABLE 25 PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 26 PAP DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.1.1 CPAP devices
7.2.1.1.1 Significantly effective in treating severe and moderate OSA
TABLE 27 CPAP DEVICES AVAILABLE IN THE MARKET
TABLE 28 CPAP DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.1.2 APAP devices
7.2.1.2.1 Sleep apnea patients who struggle to breathe out with a CPAP device find it easier to breathe using APAP devices
TABLE 29 APAP DEVICES AVAILABLE IN THE MARKET
TABLE 30 APAP DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.1.3 BiPAP devices
7.2.1.3.1 BiPAP machines have important capabilities in the treatment of COVID-19
TABLE 31 BIPAP DEVICES AVAILABLE IN THE MARKET
TABLE 32 BIPAP DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2 VENTILATORS
TABLE 33 VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 34 VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2.1 ICU ventilators
TABLE 35 ICU VENTILATORS AVAILABLE IN THE MARKET
TABLE 36 ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 37 ICU VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2.1.1 High-end ventilators
7.2.2.1.1.1 Improving healthcare infrastructure and rising healthcare expenditure to drive the adoption of high-end ventilators in developing countries
TABLE 38 HIGH-END VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2.1.2 Mid-end ventilators
7.2.2.1.2.1 Mid-end ventilators are mainly used in large and medium-sized hospitals and ambulatory care settings
TABLE 39 MID-END VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2.1.3 Basic ventilators
7.2.2.1.3.1 Basic ventilators are the most preferred for predetermined and long-term ventilation in long-term care centers, home care, and ambulatory care centers
TABLE 40 BASIC VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2.2 Portable/transportable ventilators
7.2.2.2.1 The increasing demand for home care is driving the adoption of portable/transportable ventilators
TABLE 41 PORTABLE/TRANSPORTABLE VENTILATORS AVAILABLE IN THE MARKET
TABLE 42 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.3 NEBULIZERS
7.2.3.1 Nebulizers are more effective compared to oral dosages
TABLE 43 NEBULIZERS AVAILABLE IN THE MARKET
TABLE 44 NEBULIZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.4 HUMIDIFIERS
TABLE 45 HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 46 HUMIDIFIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.4.1 Heated humidifiers
7.2.4.1.1 Ease of control and customizability drives the market growth for heated humidifiers
TABLE 47 HEATED HUMIDIFIERS AVAILABLE IN THE MARKET
TABLE 48 HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.4.2 Passover humidifiers
7.2.4.2.1 Passover humidifiers inhibit the customization of the amount of moisture delivered to patients
TABLE 49 PASSOVER HUMIDIFIERS AVAILABLE IN THE MARKET
TABLE 50 PASSOVER HUMIDIFIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.5 OXYGEN CONCENTRATORS
TABLE 51 OXYGEN CONCENTRATORS AVAILABLE IN THE MARKET
TABLE 52 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 53 OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.5.1 Fixed oxygen concentrators
7.2.5.1.1 Fixed oxygen concentrators are less expensive compared to portable oxygen concentrators
TABLE 54 FIXED OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.5.2 Portable oxygen concentrators
7.2.5.2.1 Low weight and portability to drive the growth of this segment
TABLE 55 PORTABLE OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.6 INHALERS
TABLE 56 INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 57 INHALERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.6.1 Metered-dose inhalers (MDIs)
7.2.6.1.1 MDIs are the most widely adopted inhalers among patients
TABLE 58 METERED-DOSE INHALERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.6.2 Dry powder inhalers (DPIs)
7.2.6.2.1 Lower clinical efficiency and dose variations in DPIs to restrain the market growth
TABLE 59 DRY POWDER INHALERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.7 REUSABLE RESUSCITATORS
7.2.7.1 Reusable resuscitators are economical and can be disassembled, cleaned, or reassembled as per convenience
TABLE 60 REUSABLE RESUSCITATORS OFFERED BY MAJOR PLAYERS
TABLE 61 REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 62 REUSABLE RESUSCITATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 63 ADULT RESUSCITATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 64 INFANT/NEONATAL RESUSCITATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.8 NITRIC OXIDE DELIVERY UNITS
7.2.8.1 Strong focus on developing innovative and advanced nitric oxide delivery units to boost its adoption in the coming years
TABLE 65 NITRIC OXIDE DELIVERY UNITS OFFERED BY MAJOR PLAYERS
TABLE 66 NITRIC OXIDE DELIVERY UNITS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.9 OXYGEN HOODS
7.2.9.1 The growing prevalence and recurrence of chronic lung diseases is expected to support the market growth for oxygen hoods
TABLE 67 OXYGEN HOODS OFFERED BY MAJOR PLAYERS
TABLE 68 OXYGEN HOODS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 MONITORING DEVICES
TABLE 69 RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 70 RESPIRATORY CARE MONITORING DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1 PULSE OXIMETERS
TABLE 71 PULSE OXIMETERS OFFERED BY MAJOR PLAYERS
TABLE 72 PULSE OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 73 PULSE OXIMETERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1.1 Pulse oximeter sensors
7.3.1.1.1 The use of disposable pulse oximeter sensors reduces the risk of cross-contamination and HAIs
TABLE 74 PULSE OXIMETER SENSORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1.2 Pulse oximeter equipment
7.3.1.2.1 The rising adoption of pulse oximeter equipment in home care settings is projected to drive the market growth
TABLE 75 PULSE OXIMETER EQUIPMENT OFFERED BY MAJOR PLAYERS
TABLE 76 PULSE OXIMETER EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.2 CAPNOGRAPHS
7.3.2.1 Extensive research in capnography has led to the development of advanced capnographs
TABLE 77 CAPNOGRAPHS OFFERED BY MAJOR PLAYERS
TABLE 78 CAPNOGRAPHS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.3 GAS ANALYZERS
7.3.3.1 Increasing demand for point-of-care testing to drive the demand for portable gas analyzers
TABLE 79 GAS ANALYZERS OFFERED BY MAJOR PLAYERS
TABLE 80 GAS ANALYZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4 DIAGNOSTIC RESPIRATORY CARE DEVICES
TABLE 81 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 82 DIAGNOSTIC MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.1 SPIROMETERS
7.4.1.1 Rising technological advancements in this segment to increase the adoption of spirometers
TABLE 83 SPIROMETERS OFFERED BY MAJOR PLAYERS
TABLE 84 SPIROMETERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.2 POLYSOMNOGRAPHY DEVICES (PSG DEVICES)
7.4.2.1 Rising incidence of obstructive sleep apnea to drive the growth for PSG devices
TABLE 85 POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS
TABLE 86 POLYSOMNOGRAPHY DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.3 PEAK FLOW METERS
7.4.3.1 Peak flow meters are not preferred in hospitals due to the high variability in measurements obtained from these devices
TABLE 87 PEAK FLOW METERS OFFERED BY VARIOUS PLAYERS
TABLE 88 PEAK FLOW METERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.4 OTHER DIAGNOSTIC DEVICES
TABLE 89 OTHER DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.5 CONSUMABLES & ACCESSORIES
TABLE 90 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.5.1 MASKS
TABLE 92 MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 93 MASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.5.1.1 Reusable masks
7.5.1.1.1 Rising ICU hospital admissions during the COVID-19 pandemic to drive the adoption of reusable masks
TABLE 94 REUSABLE MASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.5.1.2 Disposable masks
7.5.1.2.1 Increasing patient population for respiratory diseases to drive the growth of this segment
TABLE 95 DISPOSABLE MASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.5.2 DISPOSABLE RESUSCITATORS
7.5.2.1 Technologically advanced valves in resuscitators to drive the market growth during the forecast period
TABLE 96 DISPOSABLE RESUSCITATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.5.3 TRACHEOSTOMY TUBES
7.5.3.1 Introduction of new and advanced products with ergonomic designs to drive the market growth
TABLE 97 TRACHEOSTOMY TUBES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.5.4 BREATHING CIRCUITS
7.5.4.1 The outbreak of COVID-19 has driven the rising demand for breathing circuits
TABLE 98 BREATHING CIRCUITS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.5.5 NASAL CANNULAE
7.5.5.1 Increasing focus on minimally invasive surgery techniques is expected to boost the demand for nasal cannulae
TABLE 99 NASAL CANNULAE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.5.6 OTHER CONSUMABLES & ACCESSORIES
TABLE 100 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
8 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS (Page No. - 163)
8.1 INTRODUCTION
TABLE 101 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
8.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
8.2.1 THE INCREASING PREVALENCE OF COPD DRIVES THE DEMAND FOR RESPIRATORY CARE DEVICES
TABLE 102 GLOBAL MARKET FOR COPD, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 SLEEP APNEA
8.3.1 RISING AWARENESS FOR SLEEP APNEA DIAGNOSIS TO DRIVE THE DEMAND FOR RESPIRATORY CARE DEVICES
TABLE 103 INCREASING PREVALENCE OF SLEEP APNEA TO RAISE AWARENESS FOR ITS DIAGNOSIS
TABLE 104 GLOBAL MARKET FOR SLEEP APNEA, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 ASTHMA
8.4.1 INCREASING GLOBAL BURDEN OF ASTHMA TO SUPPORT THE MARKET GROWTH
TABLE 105 GLOBAL MARKET FOR ASTHMA, BY COUNTRY, 2019–2026 (USD MILLION)
8.5 INFECTIOUS DISEASES
8.5.1 OUTBREAK OF INFECTIOUS DISEASES TO DRIVE THE MARKET GROWTH
TABLE 106 INCIDENCE OF TB (RATE PER 100,000 POPULATION)
TABLE 107 GLOBAL MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
8.6 OTHER DISEASE INDICATIONS
TABLE 108 GLOBAL DEVICES MARKET FOR OTHER DISEASE INDICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
9 RESPIRATORY CARE DEVICES MARKET, BY END USER (Page No. - 173)
9.1 INTRODUCTION
TABLE 109 RESPIRATORY CARE DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2 HOSPITALS
9.2.1 HOSPITALS TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MARKET DURING THE FORECAST PERIOD
TABLE 110 RESPIRATORY CARE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION)
9.3 HOME CARE SETTINGS
9.3.1 RISING TECHNOLOGICAL ADVANCEMENTS HAVE LED TO THE DEVELOPMENT OF COMPACT & LIGHTWEIGHT DEVICES FOR HOME CARE
TABLE 111 GLOBAL MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2019–2026 (USD MILLION)
9.4 AMBULATORY CARE CENTERS (ACCS)
9.4.1 GRADUAL SHIFT IN PATIENT PREFERENCES FOR ACCS OVER EXPENSIVE AND EXTENDED HOSPITAL STAYS
FIGURE 36 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005–2020)
TABLE 112 GLOBAL MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
10 RESPIRATORY CARE DEVICES MARKET, BY REGION (Page No. - 180)
10.1 INTRODUCTION
FIGURE 37 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHICAL SNAPSHOT
TABLE 113 GLOBAL MARKET, BY REGION, 2019–2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 38 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET SNAPSHOT
TABLE 114 NORTH AMERICA: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 115 NORTH AMERICA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 116 NORTH AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 117 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 118 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 119 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 120 NORTH AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 121 NORTH AMERICA: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 122 NORTH AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 NORTH AMERICA: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 124 NORTH AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 NORTH AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 126 NORTH AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 127 NORTH AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 128 NORTH AMERICA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 129 NORTH AMERICA: MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 130 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.1 US
10.2.1.1 The US dominates the market in North America due to the high burden of asthma & COPD in the country
TABLE 131 US: KEY INDICATORS
TABLE 132 US: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 133 US: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 134 US: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 135 US: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 136 US: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 US: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 138 US: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 139 US: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 140 US: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 141 US: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 142 US: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 143 US: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 144 US: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 145 US: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 146 US: MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 147 US: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 The increasing incidence of COPD is driving the adoption of respiratory care devices in Canada
TABLE 148 CANADA: COPD AND ASTHMA STATISTICS (2019 VS 2020)
FIGURE 39 CANADA: ASTHMA PREVALENCE, BY AGE GROUP, 2017 VS. 2018
TABLE 149 CANADA: KEY INDICATORS
TABLE 150 CANADA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 151 CANADA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 152 CANADA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 153 CANADA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 154 CANADA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 155 CANADA: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 156 CANADA: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 157 CANADA: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 158 CANADA: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 159 CANADA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 160 CANADA: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 161 CANADA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 162 CANADA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 163 CANADA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 164 CANADA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE/ DISORDERS, 2019–2026 (USD MILLION)
TABLE 165 CANADA: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3 EUROPE
FIGURE 40 EUROPE: RESPIRATORY CARE DEVICES MARKET SNAPSHOT
TABLE 166 EUROPE: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 167 EUROPE: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 168 EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 169 EUROPE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 170 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 171 EUROPE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 172 EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 173 EUROPE: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 174 EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 175 EUROPE: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 176 EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 177 EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 178 EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 179 EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 180 EUROPE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 181 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 182 EUROPE: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Increasing healthcare expenditure and strengthening of the healthcare infrastructure in Germany to drive market growth
TABLE 183 GERMANY: KEY INDICATORS
TABLE 184 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 185 GERMANY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 186 GERMANY: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 187 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 188 GERMANY: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 189 GERMANY: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 190 GERMANY: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 191 GERMANY: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 192 GERMANY: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 193 GERMANY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 194 GERMANY: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 195 GERMANY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 196 GERMANY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 197 GERMANY: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 198 GERMANY: MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 199 GERMANY: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 The high burden of COPD is due to the increasing tobacco consumption in the country to support the market growth
TABLE 200 FRANCE: KEY INDICATORS
TABLE 201 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 202 FRANCE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 203 FRANCE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 204 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 205 FRANCE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 206 FRANCE: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 207 FRANCE: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 208 FRANCE: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 209 FRANCE: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 210 FRANCE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 211 FRANCE: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 212 FRANCE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 213 FRANCE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 214 FRANCE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 215 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 216 FRANCE: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.3 UK
10.3.3.1 The UK market has registered a favorable increase in healthcare expenditure, thus supporting the market growth
TABLE 217 UK: KEY INDICATORS
TABLE 218 UK: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 219 UK: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 220 UK: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 221 UK: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 222 UK: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 223 UK: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 224 UK: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 225 UK: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 226 UK: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 227 UK: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 228 UK: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 229 UK: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 230 UK: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 231 UK: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 232 UK: MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 233 UK: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Unfavorable healthcare reforms may negatively impact the market in Italy for respiratory care devices
TABLE 234 ITALY: KEY INDICATORS
TABLE 235 ITALY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 236 ITALY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 237 ITALY: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 238 ITALY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 239 ITALY: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 240 ITALY: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 241 ITALY: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 242 ITALY: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 243 ITALY: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 244 ITALY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 245 ITALY: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 246 ITALY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 247 ITALY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 248 ITALY: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 249 ITALY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 250 ITALY: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing debt and shortcomings in the medical devices sector to restrain market growth in Spain
TABLE 251 SPAIN: KEY INDICATORS
TABLE 252 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 253 SPAIN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 254 SPAIN: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 255 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 256 SPAIN: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 257 SPAIN: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 258 SPAIN: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 259 SPAIN: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 260 SPAIN: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 261 SPAIN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 262 SPAIN: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 263 SPAIN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 264 SPAIN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 265 SPAIN: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 266 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 267 SPAIN: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 268 ROE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 269 ROE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 270 ROE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 271 ROE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 272 ROE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 273 ROE: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 274 ROE: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 275 ROE: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 276 ROE: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 277 ROE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 278 ROE: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 279 ROE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 280 ROE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 281 ROE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 282 ROE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 283 ROE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 41 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET SNAPSHOT
TABLE 284 ASIA PACIFIC: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 285 ASIA PACIFIC: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 286 ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 287 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 288 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 289 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 290 ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 291 ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 292 ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 293 ASIA PACIFIC: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 294 ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 295 ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 296 ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 297 ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 298 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 299 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 300 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 High accessibility to healthcare services supports the market growth in Japan
TABLE 301 JAPAN: KEY INDICATORS
TABLE 302 JAPAN: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 303 JAPAN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 304 JAPAN: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 305 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 306 JAPAN: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 307 JAPAN: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 308 JAPAN: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 309 JAPAN: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 310 JAPAN: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 311 JAPAN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 312 JAPAN: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 313 JAPAN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 314 JAPAN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 315 JAPAN: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 316 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 317 JAPAN: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Healthcare development and initiatives to curb COVID-19 to stimulate the market growth for respiratory care devices in China
TABLE 318 CHINA: KEY INDICATORS
TABLE 319 CHINA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 320 CHINA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 321 CHINA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 322 CHINA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 323 CHINA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 324 CHINA: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 325 CHINA: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 326 CHINA: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 327 CHINA: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 328 CHINA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 329 CHINA: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 330 CHINA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 331 CHINA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 332 CHINA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 333 CHINA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 334 CHINA: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Rising patient population, healthcare expenditure, and medical tourism will favor the adoption of respiratory care devices in India
TABLE 335 INDIA: KEY INDICATORS
TABLE 336 INDIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 337 INDIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 338 INDIA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 339 INDIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 340 INDIA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 341 INDIA: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 342 INDIA: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 343 INDIA: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 344 INDIA: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 345 INDIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 346 INDIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 347 INDIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 348 INDIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 349 INDIA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 350 INDIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 351 INDIA: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 352 ROAPAC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 353 ROAPAC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 354 ROAPAC: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 355 ROAPAC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 356 ROAPAC: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 357 ROAPAC: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 358 ROAPAC: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 359 ROAPAC: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 360 ROAPAC: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 361 ROAPAC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 362 ROAPAC: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 363 ROAPAC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 364 ROAPAC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 365 ROAPAC: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 366 ROAPAC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 367 ROAPAC: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5 LATIN AMERICA
TABLE 368 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 369 LATIN AMERICA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 370 LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 371 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 372 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 373 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 374 LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 375 LATIN AMERICA: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 376 LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 377 LATIN AMERICA: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 378 LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET,BY TYPE, 2019–2026 (USD MILLION)
TABLE 379 LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 380 LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 381 LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 382 LATIN AMERICA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 383 LATIN AMERICA: MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 384 LATIN AMERICA: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Healthcare infrastructural improvements to drive the market growth for respiratory care devices in Brazil
TABLE 385 BRAZIL: KEY INDICATORS
TABLE 386 BRAZIL: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 387 BRAZIL: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 388 BRAZIL: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 389 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 390 BRAZIL: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 391 BRAZIL: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 392 BRAZIL: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 393 BRAZIL: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 394 BRAZIL: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 395 BRAZIL: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 396 BRAZIL: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 397 BRAZIL: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 398 BRAZIL: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 399 BRAZIL: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 400 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 401 BRAZIL: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Rising obesity rate to increase the incidence of respiratory diseases in Mexico
TABLE 402 MEXICO: KEY INDICATORS
TABLE 403 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 404 MEXICO: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 405 MEXICO: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 406 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 407 MEXICO: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 408 MEXICO: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 409 MEXICO: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 410 MEXICO: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 411 MEXICO: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 412 MEXICO: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 413 MEXICO: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 414 MEXICO: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 415 MEXICO: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 416 MEXICO: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 417 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 418 MEXICO: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5.3 REST OF LATIN AMERICA (ROLATAM)
TABLE 419 ROLATAM: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 420 ROLATAM: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 421 ROLATAM: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 422 ROLATAM: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 423 ROLATAM: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 424 ROLATAM: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 425 ROLATAM: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 426 ROLATAM: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 427 ROLATAM: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 428 ROLATAM: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 429 ROLATAM: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 430 ROLATAM: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 431 ROLATAM: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 432 ROLATAM: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 433 ROLATAM: MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 434 ROLATAM: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5.4 MIDDLE EAST & AFRICA
10.5.4.1 Growing geriatric population to drive growth in the Middle East & Africa region
TABLE 435 MEA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 436 MEA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 437 MEA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 438 MEA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 439 MEA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 440 MEA: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 441 MEA: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 442 MEA: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 443 MEA: REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 444 MEA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 445 MEA: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 446 MEA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 447 MEA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 448 MEA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 449 MEA: MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION)
TABLE 450 MEA: MARKET, BY END USER, 2019–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 304)
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY THE PLAYERS IN THE RESPIRATORY CARE DEVICES MARKET
11.3 REVENUE SHARE ANALYSIS
11.3.1 REVENUE ANALYSIS FOR KEY PLAYERS IN THE GLOBAL MARKET
FIGURE 42 REVENUE ANALYSIS FOR KEY PLAYERS IN THE RESPIRATORY CARE DEVICES MARKET IN THE PAST FIVE YEARS
11.4 MARKET SHARE ANALYSIS
11.4.1 RESPIRATORY CARE DEVICES MARKET (2020)
FIGURE 43 SHARE OF LEADING COMPANIES IN THE GLOBAL MARKET (2020)
FIGURE 44 PHILIPS HEALTHCARE: MARKET LEADER IN THE VENTILATORS MARKET, 2020
FIGURE 45 SHARE OF LEADING COMPANIES IN THE GLOBAL CPAP MARKET (2020)
FIGURE 46 PULSE OXIMETERS MARKET SHARE, BY KEY PLAYER, 2020
FIGURE 47 SPIROMETERS MARKET RANKING, BY KEY PLAYER, 2020
TABLE 451 GLOBAL MARKET: DEGREE OF COMPETITION
11.5 GEOGRAPHICAL ASSESSMENT OF THE MAJOR PLAYERS IN THE GLOBAL MARKET
11.6 COMPETITIVE ASSESSMENT OF R&D EXPENDITURE
FIGURE 48 R&D EXPENDITURE OF KEY PLAYERS IN THE RESPIRATORY CARE DEVICES MARKET, 2019 VS. 2020 (USD MILLION)
11.7 COMPETITIVE LEADERSHIP MAPPING
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 PARTICIPANTS
FIGURE 49 RESPIRATORY CARE DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
11.8 COMPANY EVALUATION QUADRANT FOR SMES/START-UPS (2020)
11.8.1 PROGRESSIVE COMPANIES
11.8.2 DYNAMIC COMPANIES
11.8.3 STARTING BLOCKS
11.8.4 RESPONSIVE COMPANIES
FIGURE 50 RESPIRATORY CARE DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR SMES/START-UPS, 2020
11.9 COMPETITIVE BENCHMARKING
FIGURE 51 COMPANY PRODUCT FOOTPRINT (25 COMPANIES)
TABLE 452 COMPANY SERVICE OFFERING FOOTPRINT (25 COMPANIES)
TABLE 453 COMPANY INDICATION FOOTPRINT (25 COMPANIES)
TABLE 454 COMPANY END-USER FOOTPRINT (25 COMPANIES)
11.1 COMPETITIVE SITUATIONS AND TRENDS
11.10.1 PRODUCT LAUNCHES
11.10.2 OTHER DEVELOPMENTS
11.10.3 DEALS
12 COMPANY PROFILES (Page No. - 325)
12.1 KEY PLAYERS
(Business overview, Products and services offered, Recent Developments, MNM view)*
12.1.1 PHILIPS HEALTHCARE
TABLE 455 PHILIPS HEALTHCARE: BUSINESS OVERVIEW
FIGURE 52 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2020)
FIGURE 53 QUARTERLY REVENUE ANALYSIS: PHILIPS (CONNECTED CARE)
12.1.2 MEDTRONIC PLC
TABLE 456 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 54 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
FIGURE 55 QUARTERLY REVENUE ANALYSIS: MEDTRONIC (RGR)
12.1.3 RESMED, INC.
TABLE 457 RESMED, INC.: BUSINESS OVERVIEW
FIGURE 56 RESMED, INC.: COMPANY SNAPSHOT (2020)
FIGURE 57 QUARTERLY REVENUE ANALYSIS: RESMED, INC.
12.1.4 MASIMO CORPORATION
TABLE 458 MASIMO CORPORATION: BUSINESS OVERVIEW
FIGURE 58 MASIMO CORPORATION: COMPANY SNAPSHOT (2020)
12.1.5 FISHER & PAYKEL HEALTHCARE CO. LTD.
TABLE 459 FISHER & PAYKEL HEALTHCARE CO. LTD.: BUSINESS OVERVIEW
FIGURE 59 FISHER & PAYKEL HEALTHCARE CO. LTD.: COMPANY SNAPSHOT (2020)
12.1.6 DRÄGERWERK AG & CO.
TABLE 460 DRÄGERWERK AG & CO.: BUSINESS OVERVIEW
FIGURE 60 DRÄGERWERK AG & CO.: COMPANY SNAPSHOT (2020)
FIGURE 61 QUARTERLY REVENUE ANALYSIS: DRÄGERWERK AG & CO. (MEDICAL DIVISION)
12.1.7 GETINGE AB
TABLE 461 GETINGE AB: BUSINESS OVERVIEW
FIGURE 62 GETINGE AB: COMPANY SNAPSHOT (2020)
FIGURE 63 QUARTERLY REVENUE ANALYSIS: GETINGE AB (ACUTE CARE THERAPIES)
12.1.8 NIHON KOHDEN CORPORATION
TABLE 462 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW
FIGURE 64 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2020)
12.1.9 GENERAL ELECTRIC HEALTHCARE (GE ELECTRIC)
TABLE 463 GENERAL ELECTRIC: BUSINESS OVERVIEW
FIGURE 65 GENERAL ELECTRIC: COMPANY SNAPSHOT (2020)
12.1.10 VYAIRE MEDICAL
TABLE 464 VYAIRE MEDICAL: BUSINESS OVERVIEW
12.1.11 HILL-ROM, INC.
TABLE 465 HILL-ROM, INC.: BUSINESS OVERVIEW
FIGURE 66 HILL-ROM, INC.: COMPANY SNAPSHOT: COMPANY SNAPSHOT (2020)
12.1.12 ADAPTHEALTH, LLC.
TABLE 466 ADAPTHEALTH, LLC.: BUSINESS OVERVIEW
FIGURE 67 ADAPTHEALTH, LLC.: COMPANY SNAPSHOT (2020)
12.1.13 ROTECH HEALTHCARE, INC.
TABLE 467 ROTECH HEALTHCARE INC.: BUSINESS OVERVIEW
FIGURE 68 ROTECH HEALTHCARE INC.: COMPANY SNAPSHOT (2020)
12.1.14 TELEFLEX INCORPORATED
TABLE 468 TELEFLEX INCORPORATED: BUSINESS OVERVIEW
FIGURE 69 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2020)
12.1.15 AIR LIQUIDE
TABLE 469 AIR LIQUIDE: BUSINESS OVERVIEW
FIGURE 70 AIR LIQUIDE: COMPANY SNAPSHOT (2020)
12.2 OTHER PLAYERS
12.2.1 INVACARE CORPORATION
TABLE 470 INVACARE CORPORATION: BUSINESS OVERVIEW
FIGURE 71 INVACARE CORPORATION: COMPANY SNAPSHOT (2020)
12.2.2 SMITHS MEDICAL
TABLE 471 SMITHS MEDICAL: BUSINESS OVERVIEW
FIGURE 72 SMITHS MEDICAL: COMPANY SNAPSHOT (2020)
12.2.3 HAMILTON MEDICAL AG
TABLE 472 HAMILTON MEDICAL AG: BUSINESS OVERVIEW
12.2.4 APEX MEDICAL CORPORATION
TABLE 473 APEX MEDICAL CORPORATION: BUSINESS OVERVIEW
12.2.5 MEDLINE INDUSTRIES, INC.
TABLE 474 MEDLINE INDUSTRIES, INC.: BUSINESS OVERVIEW
12.2.6 HUM GMBH
TABLE 475 HUM GMBH: BUSINESS OVERVIEW
12.2.7 NONIN
12.2.8 ALLIED HEALTHCARE PRODUCTS, INC.
12.2.9 DRIVE DEVILBISS HEALTHCARE
12.2.10 OMRON HEALTHCARE, INC.
*Details on Business overview, Products and services offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 411)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This study involved four major activities for estimating the current size of the global respiratory care devices market. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step focused on validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the sizes of segments and sub-segments.
Secondary Research
In the secondary research process, various secondary sources such as D&B Hoovers, Bloomberg Business, and Factiva have been referred to identify and collect information for this study. These secondary sources include annual reports, press releases and investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard and silver-standard websites, regulatory bodies, and databases.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies operating in the respiratory care devices market. Primary sources from the demand side include experts from hospitals and diagnostic labs and research and academic laboratories. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on the key industry trends and key market dynamics, such as market drivers, restraints, challenges, and opportunities.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the respiratory care devices market was arrived at after data triangulation from four different approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.
Approach 1: Supply-side Analysis (Revenue Share Analysis)
Revenues of individual companies were gathered from public sources and databases. Shares of the respiratory care devices businesses of leading players were gathered from secondary sources to the extent available. In certain cases, shares of the respiratory care devices businesses were ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, selling price, and geographic reach and strength. Individual shares or revenue estimates were validated through expert interviews.
Approach 2: Obtained from the annual presentations and investor presentations of leading players to estimate market growth
The respiratory care devices market size was obtained from the annual presentations and investor presentations of leading players. Shares of different product types in the overall respiratory care devices market were obtained from secondary data and validated by primary participants to arrive at the total market size. Primary participants validated the numbers. As part of the primary research process, individual respondents’ insights into the market size and market growth were taken during the interview (regional and global, as applicable). All responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.
Approach 3: Market segment assessment (By Product and End User)
The segmental assessment was conducted using the following approaches:
Approach for Product: Splits for segments were derived by studying the usage of various respiratory care products considered in the study.
Approach for Disease Indications: Splits for segments were derived by studying the adoption of products in various diseases. This information was validated through primary interviews. The adoption of various products for each disease indications segment was assessed to arrive at the percentage splits.
Approach for End User: Splits for segments were derived by studying the adoption patterns of products by different end users in the respiratory care devices market. This information was validated through primary interviews.
Approach 4: Geographic market assessment (By Country)
The geographic assessment was undertaken using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual application segments and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall respiratory care devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of leading players in a particular region or country.
Data Triangulation
After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Objectives of the Study
- To define, describe, and forecast the respiratory care devices market based on type, disease indications, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa
- To profile key market players and comprehensively analyze their product portfolios, market shares, and core competencies
- To track and analyze competitive developments, such as product launches, expansions, acquisitions, agreements, and collaborations in the respiratory care devices market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographic Analysis
- A further breakdown of the Rest of Europe respiratory care devices market into the Netherlands, Belgium, Switzerland, and other countries
- A further breakdown of the Rest of the Asia Pacific respiratory care devices market into New Zealand and other countries
- A further breakdown of the Middle East and Africa respiratory care devices market into South Africa, Saudi Arabia and other countries
Company Information
- Detailed analysis and profiling of additional market players
Growth opportunities and latent adjacency in Respiratory Care Devices Market